Northern Gritstone has invested into Manchester spinout Cytotrait as part of a £3m seed funding round.

Cytotrait is a biotechnology spinout from The University of Manchester commercialised with support from the University of Manchester Innovation Factory.

It is focused on the development of novel traits for food and agriculture.

The £3 million round was led by Northern Gritstone, with contributions from the UK Innovation & Science Seed Fund (UKI2S, managed by Future Planet Capital), and Northern Universities Ventures Fund, managed by Parkwalk in collaboration with Northern Gritstone.